Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Revenue

Medprin Regenerative Medical Technologies had revenue of 78.36M CNY in the quarter ending March 31, 2026, with 6.32% growth. This brings the company's revenue in the last twelve months to 373.49M, up 26.63% year-over-year. In the year 2025, Medprin Regenerative Medical Technologies had annual revenue of 368.83M with 32.46% growth.

• Revenue (ttm): 373.49M
• Revenue Growth: +26.63%
• P/S Ratio: 9.95
• Revenue / Employee: 1.11M
• Employees: 337
• Market Cap: 3.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	368.83M	90.39M	32.46%
Dec 31, 2024	278.44M	47.57M	20.61%
Dec 31, 2023	230.87M	35.62M	18.24%
Jan 1, 2023	195.25M	41.47M	26.96%
Jan 1, 2022	153.79M	30.27M	24.51%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error